文献速递焦虑、强迫与应激相关障碍心境障碍

MDMA与裸盖菇素调节恐惧大鼠模型少突胶质谱系细胞数量及焦虑样行为

MDMA and Psilocybin Regulate Oligodendrocyte-Lineage Cell Numbers and Anxiety-Like Behaviors in a Rat Model of Fear.
PubMed 文献 · Biol Psychiatry · 2026-02-03

该研究在情境恐惧条件化成年雄性Wistar大鼠(N=210)中,重复低剂量给予裸盖菇素(0.5 mg/kg,腹腔注射,4天)或MDMA(0.1 mg/kg/天,腹腔注射,4天),发现两者均减少焦虑样行为,并伴随少突胶质细胞变化及髓鞘相关重塑的多组学特征;髓鞘破坏可消除抗焦虑效应,5-HT2A受体阻断完全取消两种药物诱导的髓鞘与行为改善。

要点

  • 裸盖菇素与MDMA均减少恐惧条件化大鼠的焦虑样行为,并促进少突胶质细胞与髓鞘可塑性。
  • 髓鞘完整性被破坏后抗焦虑效应消失,提示髓鞘重塑参与药物行为效应。
  • 5-HT2A受体阻断完全取消两种药物诱导的髓鞘与行为改善。

核心结论

  • 裸盖菇素和MDMA促进成年少突胶质细胞及髓鞘可塑性,增强髓鞘化可能是增强或维持致幻剂辅助治疗PTSD及相关障碍疗效的可行策略。

研究设计与样本

  • 成年雄性Wistar大鼠(N=210)接受重复低剂量裸盖菇素(0.5 mg/kg,腹腔注射,4天)或MDMA(0.1 mg/kg/天,腹腔注射,4天),行为学评估焦虑样行为与空间记忆,并局部及全局操纵髓鞘完整性。
  • 采用髓鞘厚度定量、少突胶质谱系细胞密度及齿状回转录组、蛋白质组和代谢组分析评估药物对髓鞘化的影响。

主要发现

  • 两种化合物均减少焦虑样行为,伴随少突胶质变化及髓鞘相关重塑的多组学特征。
  • 完整恐惧条件化动物中,有无致幻剂处理的平均g-ratio髓鞘厚度测量无显著差异。
  • 髓鞘破坏消除抗焦虑效应,整合多组学显示裸盖菇素或MDMA给药后髓鞘相关蛋白趋同上调。
  • 裸盖菇素优先诱导早期少突胶质基因程序,而MDMA增强成熟髓鞘标志物。
  • 5-HT2A受体阻断完全取消裸盖菇素和MDMA诱导的髓鞘与行为改善。

关键数值与推荐

  • 裸盖菇素剂量为0.5 mg/kg,腹腔注射,持续4天;MDMA剂量为0.1 mg/kg/天,腹腔注射,持续4天。
  • 成年雄性Wistar大鼠样本量为N=210。

临床怎么用

  • 在恐惧相关障碍的致幻剂辅助治疗研究中,可关注髓鞘可塑性作为潜在治疗靶点及疗效增强策略。
  • 5-HT2A受体信号与髓鞘重塑的关联提示受体机制可能介导裸盖菇素和MDMA的行为效应。

局限性

  • 研究仅使用成年雄性Wistar大鼠的情境恐惧条件化模型,结果外推至人类及其他人群需谨慎。
  • 平均g-ratio在完整恐惧条件化动物中未显示显著组间差异,髓鞘厚度指标未能完全反映药物效应。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Psilocybin and MDMA produce rapid, enduring therapeutic effects in posttraumatic stress disorder (PTSD); however, the underlying cellular mechanisms remain incompletely understood. In this study, we investigated whether adult myelin plasticity contributes to the therapeutic actions of psilocybin and MDMA in a rat model of contextual fear conditioning. METHODS: Adult male Wistar rats (N = 210) received repeated low doses of psilocybin (0.5 mg/kg, intraperitoneally [i.p.], for 4 days) or MDMA (0.1 mg/kg/day, i.p., for 4 days). Behavioral tests assessed anxiety-like behaviors and spatial memory. Following local and global manipulations of myelin integrity, we assessed the drugs' effects on myelination by quantifying myelin sheath thickness; oligodendrocyte-lineage cell densities; and transcriptomic, proteomic, and metabolomic profiles in the dentate gyrus. RESULTS: Both compounds reduced anxiety-like behaviors. These improvements coincided with oligodendroglial changes and multiomic signatures of myelin-related remodeling; however, mean g-ratio measures of myelin thickness did not differ significantly between intact fear-conditioned animals with or without psychedelic treatment. Myelin disruption abolished these anxiolytic effects, and integrative multiomics revealed convergent upregulation of myelin-related proteins following administration of psilocybin or MDMA. Psilocybin preferentially induced early oligodendroglial gene programs, while MDMA enhanced markers of mature myelin. Notably, 5-HT2A receptor blockade completely abolished the myelin and behavioral enhancements induced by both psilocybin and MDMA. CONCLUSIONS: Psilocybin and MDMA promote adult oligodendrocyte and myelin plasticity. Enhancing myelination may be a viable strategy to augment or sustain the therapeutic effects of psychedelic-assisted treatments for PTSD and related disorders.

来源:Biol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Bostancıklıoğlu M, Kaplan DS, Bal R, et al. MDMA and Psilocybin Regulate Oligodendrocyte-Lineage Cell Numbers and Anxiety-Like Behaviors in a Rat Model of Fear. Biol Psychiatry. 2026. PMID: 41644029. doi:10.1016/j.biopsych.2026.01.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。